$CALC +45% PREMARKET 🚀 🔹 Big early move as traders jump into this low-float biotech setup 📈 🔹 CalciMedica is developing CRAC channel inhibition therapies fo

$CALC +45% PREMARKET 🚀 🔹 Big early move as traders jump into this low-float biotech setup 📈 🔹 CalciMedica is developing CRAC channel inhibition therapies for inflammatory, immunologic, and cardiopulmonary diseases 🧬 🔹 Lead program Auxora targets major unmet needs including acute pancreatitis a…